Author details

Full Name

Derek M Yellon

Affiliation

ORCID

Career Start Year

1979

Papers

498

H Index

114

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34739648	Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial.	Cardiovascular Drugs and Therapy	2023
36301452	Nicorandil - an Effective Multitarget Drug for Cardioprotection?	Cardiovascular Drugs and Therapy	2023
37839355	Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection.	Redox Biol	2023
37417240	Remote Ischemic Conditioning: Challenges and Opportunities.		2023
36889041	Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.	Mol Genet Metab	2023
37397080	Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning.		2023
37445326	Defining Peri-Operative Myocardial Injury during Cardiac Surgery Using High-Sensitivity Troponin T.		2023
37233787	The RISK pathway leading to mitochondria and cardioprotection: how everything started.		2023
37225977	A small-molecule PI3KÎ± activator for cardioprotection and neuroregeneration.		2023
35322592	Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure.	ESC Heart Fail	2022
35970954	Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.	Basic Research in Cardiology	2022
35793001	Opioids in Acute Coronary Syndromes: Friend or Foe?	Cardiovascular Drugs and Therapy	2022
35727392	Negative interaction between nitrates and remote ischemic preconditioning in patients undergoing cardiac surgery: the ERIC-GTN and ERICCA studies.	Basic Research in Cardiology	2022
36446868	Fasting increases susceptibility to acute myocardial ischaemia/reperfusion injury through a sirtuin-3 mediated increase in fatty acid oxidation.	Scientific Reports	2022
36445625	Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.	Cardiovascular Drugs and Therapy	2022
34232434	Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.	Cardiovascular Drugs and Therapy	2022
34169381	RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.	Cardiovascular Drugs and Therapy	2022
33878183	Extracellular histones are a target in myocardial ischaemia-reperfusion injury.	Cardiovascular Research	2022
33386841	Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.	Cardiovascular Research	2022
35171384	Do We Really Need Aspirin Loading for STEMI?	Cardiovasc Drugs Ther	2022
35347928	Cardio-oncology Issues in Lymphoma Patients.	Israel Medical Association Journal	2022
34648075	Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy.	Basic Research in Cardiology	2021
32163139	Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2/ERIC-PPCI randomized controlled trial.	Cardiovascular Research	2021
33797200	Exosomes from neuronal stem cells may protect the heart from ischaemia/reperfusion injury via JAK1/2 and gp130.	Journal of Cellular and Molecular Medicine	2021
33629195	Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response.	Basic Research in Cardiology	2021
34107730	Remote Ischemic Preconditioning Protects Against Endothelial Dysfunction in a Human Model of Systemic Inflammation: A Randomized Clinical Trial.	Arteriosclerosis, Thrombosis, and Vascular Biology	2021
33942194	Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke.	Basic Research in Cardiology	2021
34037861	Translation of experimental cardioprotective capability of P2Y inhibitors into clinical outcome in patients with ST-elevation myocardial infarction.	Basic Research in Cardiology	2021
34193829	Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.	Cell Death and Disease	2021
33057804	Targeting myocardial ischaemic injury in the absence of reperfusion.	Basic Research in Cardiology	2020
32246632	Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?	Neural Regeneration Research	2020
32357233	Professor Lionel H. Opie 6th May 1933-20th February 2020.	Eur Heart J	2020
32062794	The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium.	Cardiovascular Drugs and Therapy	2020
32101370	Increased production of functional small extracellular vesicles in senescent endothelial cells.	Journal of Cellular and Molecular Medicine	2020
32335728	A future for remote ischaemic conditioning in high-risk patients.	Basic Research in Cardiology	2020
32146560	Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential.	Basic Research in Cardiology	2020
33258000	Mouse models of atherosclerosis and their suitability for the study of myocardial infarction.	Basic Research in Cardiology	2020
32594778	The cytokine storm of COVID-19: a spotlight on prevention and protection.	Expert Opinion on Therapeutic Targets	2020
33037284	Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study.	Scientific Reports	2020
33188438	The importance of clinically relevant background therapy in cardioprotective studies.	Basic Research in Cardiology	2020
31356550	Role of Caspase 1 in Ischemia/Reperfusion Injury of the Myocardium.	Journal of Cardiovascular Pharmacology	2019
31721014	Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide.	Cardiovascular Drugs and Therapy	2019
31815634	Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study.	Cardiovasc Diabetol	2019
34396186	Preventing the Cancer Patient ofÂ TodayÂ FromÂ Becoming the HeartÂ FailureÂ PatientÂ of Tomorrow.	JACC: CardioOncology	2019
30651940	Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential.	Journal of Extracellular Vesicles	2019
30621955	Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACCÂ ReviewÂ TopicÂ ofÂ theÂ Week.	Journal of the American College of Cardiology	2019
30738798	Stromal cell-derived factor-1Î± signals via the endothelium to protect the heart against ischaemia-reperfusion injury.	Journal of Molecular and Cellular Cardiology	2019
30847415	SGLT2 Inhibitor, Canagliflozin, AttenuatesÂ Myocardial Infarction in theÂ DiabeticÂ and Nondiabetic Heart.	JACC: Basic to Translational Science	2019
29582211	The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.	Cardiovascular Drugs and Therapy	2018
28840975	Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro.	Journal of Cellular and Molecular Medicine	2018